Americaine — Class I drug recall D-0236-2024
Completed recall by Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, reported 2024-01-24, distributed nationwide. Chemical Contamination: presence of benzene
| Recall number | D-0236-2024 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company, Tarrytown, NY, United States |
| Recall initiated | 2023-12-21 |
| Classified | 2024-01-17 |
| Reported by FDA | 2024-01-24 |
| Distributed | Nationwide (US) |
| Quantity | 34,704 cans |
| Reason classes | chemical contamination |
| UPC / GTIN / UDI-DI | 00363736378820 |
| NDC | 63736-0378, 63736-0378-02 |
| Lot numbers | 1A16420 |
| Expiration dates | 2025-01-31 |
Product
Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight Pharmaceuticals Corp. Tarrytown, NY 10591, USA, A Prestige Consumer Healthcare company. Made in India. NDC 63736-378-02, Can UPC 3 63736 37882 0; Case UPC 1 03 63736 37882 7
Reason for recall
Chemical Contamination: presence of benzene
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0236-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.